BioCardia Says Based On Interim Results In Autologous CardiAMP Cell Therapy For Treatment Of Heart Failure, Co. Is Exploring Development Of a New Phase 3 Clinical Trial Protocol; CardiAMP HF Trial Showed
September 6, 7:17 AM
BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced a clarification and next steps on its autologous
September 5, 2:30 PM
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P 500, also fell, dropping, 0.22% to 4,505.65.
Why America’s Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
September 5, 1:34 PM
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform TikTok.
September 5, 1:31 PM
Gainers First Wave BioPharma (NASDAQ:FWBI) stock increased by 136.2% to $0.69 during Tuesday’s regular session. Trading volume for…